Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty-Reference-Cited by-同舟云学术

Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty

Published:2021-11-23 Issue:1 Volume:22 Page:39-51
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Nguyen Mike¹^ORCID,Segelov Eva¹,Goldstein David²,Pavlakis Nick³,Shapiro Jeremy⁴,Price Timothy J⁵^ORCID,Nagrial Adnan⁶,Chantrill Lorraine⁷,Leong Trevor⁸,Chen John⁹,Burge Matt¹⁰,Karapetis Christos S⁹,Chau Ian¹¹,Lordick Florian¹²,Renouf Daniel¹³,Tebbutt Niall¹⁴,Roy Amitesh C.⁹

Affiliation:

1. Department of Medical Oncology, School of Clinical Sciences, Monash University and Monash Health, Melbourne, Australia

2. Department of Medical Oncology, Prince of Wales Hospital, University of NSW, Sydney, Australia

3. Department of Medical Oncology, Royal North Shore Hospital, University of Sydney, Sydney, Australia

4. Cabrini Health, Monash University, Melbourne, Australia

5. Department of Haematology and Oncology, The Queen Elizabeth Hospital/University of Adelaide, Adelaide, Australia

6. Department of Medical Oncology, Westmead & Blacktown Hospitals, University of Sydney, Sydney, Australia

7. Department Medical Oncology, Wollongong Hospital, Illawarra Shoalhaven Local Health District, Australia

8. Division of Radiation Oncology, Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia

9. Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, Australia

10. Department of Cancer Care Services, Royal Brisbane Hospital, University of Queensland, Herston, Australia

11. Department of Medicine, Royal Marsden Hospital, Institute of Cancer Research, Surrey, London, UK

12. University Cancer Center Leipzig and Department of Oncology, Gastroenterology, Hepatology, Pneumology and Infectious Diseases, Leipzig University Medical Center, Leipzig, Germany

13. Department of Medical Oncology, BC Cancer. Faculty of Medicine, University of British Columbia, Vancouver, Canada

14. Department of Medical Oncology, Olivia Newton-John Cancer Wellness and Research Centre. Austin Health, Heidelberg, Australia

Funder

Bristol Myers Squibb, Merck, and Specialised Therapeutics to the Australasian Gastrointestinal Trials Group

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2022.2002689

Reference113 articles.

1. Estimated Projection of US Cancer Incidence and Death to 2040

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Pancreatic cancer statistics | World Cancer Research Fund International [Internet]. [cited 2021 Jul 4]. Available from: https://www.wcrf.org/dietandcancer/pancreatic-cancer-statistics/

4. Cancer data in Australia, How are pancreatic cancer rates changing? Australian Institute of Health and Welfare [Internet]. [cited 2021 Aug 5]. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/cancer-data-commentaries/how-are-pancreatic-cancer-rates-changing

5. Adjuvant chemotherapy in pancreatic cancer: state of the art and future perspectives